Stimulatory effect of arachidonic acid on T-47D human breast cancer cell growth is associated with enhancement of cyclin D1 mRNA expression

Nutrition and Cancer

Volumn 38, Issue 2, 2000, Pages 274-280

  Razanamahefa, L ^a   Prouff, S ^a   Bardon, S ^a  

^a CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLIN D1; POLYUNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL CYCLE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GENE ISOLATION; NONHUMAN; NORTHERN BLOTTING; RAT;

ANIMALIA;

EID: 0034434407     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC382_17     Document Type: Article

References (59)

1. Essential fatty acids in health and chronic disease
2. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: Emerging evidence for their role as risk modifiers
3. Dietary fat and cancer: Consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption
4. An ecological study of the relationship between dietary fat intake and breast cancer mortality
5. Dietary polyunsaturated fat versus saturated fat in relation to mammary carcinogenesis
6. Requirement of essential fatty acid for mammary tumorigenesis in the rat
7. Dietary fat and mammary cancer. I. Promoting effects of different dietary fats on N-nitrosomethylurea-induced rat mammary tumorigenesis
8. Effect of different types and amounts of fat on the development of mammary tumors in rodents: A review
9. Effects of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice
10. Dietary fat and breast cancer metastasis by human tumor xenografts
11. Effects of fatty acids inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture
12. Effects of linoleic acid on mammary tumor cell proliferation are associated with changes in p53 protein expression
13. Metabolic conversion and growth effects of n-6 and n-3 polyunsaturated fatty acids in the T47D breast cancer cell line
14. Stimulation of type IV collagenase expression by linoleic acid in a metastatic human breast cancer cell line
15. Effect of ω-6 polyunsaturated fatty acid (linoleic acid) on BRCA1 gene expression in MCF-7 cell line
16. The effects of n-6 polyunsaturated fatty acids on the expression of nm23 in human cancer cells
17. Fatty acid-induced modifications of mouse mammary alveolar lesions in organ culture
18. Dietary fatty acids and breast cancer and metastasis
19. Tumor cell-endothelial cell interactions: Evidence for roles for lipoxygenase products of arachidonic acid in metastasis
20. 2 activity in 9,10-dimethyl-1,2-benzanthracene-induced mammary tumors of rats
21. 2 activity in MDA-MB-435 human breast cancer cells
22. kip2 and their interactions with other cycle regulators in cancer cells
23. Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway
24. Effects of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells
25. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids
26. Cytotoxicity of arachidonic acid and of its lipoxygenase metabolite 15-hydroperoxyeicosatetraenoic acid on human breast cancer MCF-7 cells in culture
27. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation
28. n-3 and n-6 fatty acid processing and growth effects in neoplastic and noncancerous human mammary epithelial cell lines
29. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
30. Function of a human cyclin gene as an oncogene
31. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines
32. Establishment and characterization of a cell line of human breast carcinoma origin
33. A fluorometric deoxyribonucleic acid assay for tridimensional lattice cultures of fibroblasts
34. RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor
35. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
36. Human D-type cyclin
37. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture
38. Cell cycle regulators: Mechanisms and their role in aetiology, prognosis, and treatment of cancer
39. The retinoblastoma protein and cell cycle control
40. Cyclin D1 protein expression and function in human breast cancer
41. 1 to complete the cell cycle
42. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression
43. Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin D1-transfected human fibrosarcoma cells
44. Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro
45. 3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF7-cells
46. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2
47. Retinoic acid suppresses insulininduced cell growth and cyclin D1 gene expression in human breast cancer cells
48. The cell cycle and development: Redundant roles of cell cycle regulators
49. Dietary fat and carcinogenesis
50. The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma
51. Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells
52. Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase
53. A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid
54. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators
55. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
56. Peroxisome proliferator-activated receptors-α and -γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
57. MCF-7 and T-47D human breast cancer cells contain a functional peroxisomal response
58. Differential transcriptional activation of peroxisome proliferator-activated receptor-γ by ω-3 and ω-6 fatty acids in MCF-7 cells
59. Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of γ-linolenic acid in breast cancer cells